Boehringer Ingelheim exercises option to license additional Dark Antigens from a wider array of tumor types, expanding Enara’s eligibility for milestone payments under existing collaboration  Scott ...

Immunotherapies have already shown startling effectiveness against certain previously intractable cancers and a pair of scientists were awarded this year’s Nobel Prize for their research into immune ...

April 17, 2020, Sino Biological announced this week that the company launched the world’s first coronavirus antigen array under its new brand Sinommune TM. This product is co-developed by Nanommune ...

Figure 1: A schematic diagram that illustrates the steps involved in content generation, processing and data analysis for antigen microarrays. Antigen-specific tolerization with epitopes of oral type ...

Antigen microarrays hold great promise for profiling the humoral immune response in the settings of autoimmunity, allergy and cancer. This approach involves immobilizing antigens on a slide surface ...

Sino Biological, Inc. today announced a co-development agreement with Nanommune Inc., an Irvine, California based biotechnology company specializing in the development and application of multiplex ...

In a recent study posted to the medRxiv preprint* server, researchers pursued evidence of whether severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigens, of which spike (S) protein is ...